Epigenomics: Emerging Opportunities in Biomarkers, Diagnostics and Therapeutics

Global market for Epigenomic Products was $662 billion in 2008, which increased to $930.6 million 2009, it is projected to reach $6 billion in 2014 at a 5 year CAGR of 45.4%.

Learn major Epigenomics technologies impacting the market today and emerging opportunities in biomarkers, diagnostics and therapeutics through 2014...

Use this report to:


• Receive a comprehensive discussion of where the state of the art is in epigenomics technologies and the current and future commercial potential for these key market segments, along with a study of the current large-scale epigenome funding projects as well as the industry competitive and patent dynamics


• Determine the status of commercial epigenomics technologies and products and assess their worldwide growth potential over a 5 year period from 2009 through 2014; by the four main segments for epigenomics: research tools, diagnostics, therapeutics, and assays for cellular therapies


• See the major epigenomics technologies that are now, or likely to become commercialized within the next 5 years, and examine the products from these technologies, market segments of the products, and sales forecasts and trends for 2009 through 2014


• Understand the fundamental epigenomic technologies, the market driving forces, product types, main market applications, key companies, strategic alliances and acquisitions, future global market potential and product sales forecasts for the period of 2009 through 2014.


Click here for more detailed information.


To provide further information about this report we offer a Complimentary Introduction, available from our Website. To download, simply click here, go to the Table of Contents tab, add the complimentary introduction to your cart, and confirm your order.